G Barbarini

Author PubWeight™ 45.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Retracted Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 1998 4.93
2 Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial. J Hepatol 2001 2.22
3 Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. AIDS 1990 2.15
4 Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol 1999 1.81
5 Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial. Am J Med 1999 1.55
6 Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study. Am J Gastroenterol 1998 1.53
7 Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study. Hepatology 1998 1.49
8 Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience. Ribavirin-Interferon in Chronic Hepatitis Italian Group Investigators. J Hepatol 2000 1.47
9 Retracted Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase. AIDS 2000 1.45
10 Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. AIDS Res Hum Retroviruses 1998 1.29
11 Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol 1999 0.98
12 Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension. Heart 2006 0.97
13 Primary pulmonary hypertension in HIV patients: a systematic review. Angiology 2001 0.97
14 Asymptomatic respiratory tract microsporidiosis due to Encephalitozoon hellem in three patients with AIDS. Clin Infect Dis 1998 0.97
15 Hepatitis C virus (HCV) core serotypes in chronic HCV infection. J Clin Microbiol 1994 0.94
16 Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol 1996 0.92
17 Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis. Heart 2006 0.89
18 Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. Chest 1996 0.88
19 Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: a multicenter echocardiographic and echo-Doppler study. The Gruppo Italiano Per lo Studio Cardiologico dei Pazienti Affetti da AIDS. AIDS Res Hum Retroviruses 1996 0.87
20 Hepatitis C infection in Italian psoriatic patients: prevalence and correlation with patient age and psoriasis severity. J Eur Acad Dermatol Venereol 2011 0.86
21 Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy. Clin Infect Dis 2001 0.86
22 Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis. Gastroenterology 1996 0.86
23 Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). Circulation 1999 0.85
24 HIV-associated coronary arteritis in a patient with fatal myocardial infarction. N Engl J Med 2001 0.84
25 Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients. Infection 2009 0.84
26 Coronary artery bypass graft in HIV-infected patients: a multicenter case control study. Curr HIV Res 2008 0.83
27 Prevalence of dermatophytes and yeasts (Candida spp., Malassezia furfur) in HIV patients. A study of former drug addicts. Mycopathologia 1991 0.82
28 Vagal system impairment in human immunodeficiency virus-positive patients with chronic hepatitis C: does hepatic glutathione deficiency have a pathogenetic role? Scand J Gastroenterol 1997 0.82
29 Highly active antiretroviral therapy in HIV-associated pulmonary hypertension. Minerva Cardioangiol 2005 0.81
30 Costs and benefits of diagnostic and therapeutic methods in Salmonella infections. Boll Ist Sieroter Milan 1985 0.81
31 Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha. Multicenter Interferon Beta Italian Group Investigators. Scand J Gastroenterol 1999 0.80
32 Kawasaki-like syndrome in an HIV-infected adult. Rheumatology (Oxford) 2003 0.79
33 Longitudinal neuropsychological evaluation of HIV-infected intravenous drug users. Addiction 1996 0.78
34 Clinical meaning of ventricular ectopic beats in the diagnosis of HIV-related myocarditis: a retrospective analysis of Holter electrocardiographic recordings, echocardiographic parameters, histopathological and virologic findings. Cardiologia 1996 0.78
35 Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study. Eur J Emerg Med 1998 0.78
36 A new approach to safely type for HLA the HIV infected people eligible to abacavir therapy: saliva or buccal swab as reliable DNA sources. Clin Chim Acta 2011 0.77
37 Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study. J Viral Hepat 2011 0.76
38 Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. Endoscopy 1995 0.76
39 Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. Scand J Infect Dis 1995 0.76
40 Effect of recombinant human granulocyte-macrophage colony-stimulating factor on HIV-related leukopenia: a randomized, controlled clinical study. AIDS 1997 0.76
41 Management of chronic hepatitis in drug addicts: a systematic review. Clin Ter 2008 0.75
42 [Observations about the use of different types of enzymes in immunohistological diagnosis of autoimmune diseases. Comparative study with indirect immunofluorescence technique (author's transl)]. Ann Sclavo 1981 0.75
43 Bacterial toxins and glucagon in liver cAMP regulation: a physiopathological role in liver diseases? Boll Ist Sieroter Milan 1980 0.75
44 Hepatic iron storage and megamitochondria formation in patients with chronic hepatitis C related to the hepatitis C virus genotype. Dig Liver Dis 2001 0.75
45 An eleven year survey (1975-1985) of fulminant hepatitis: considerations on epidemiology and pathogenesis. Boll Ist Sieroter Milan 1986 0.75
46 Absence of antibodies to HIV in long term institutionalized psychiatric patients. Eur J Epidemiol 1989 0.75
47 Possible antiendotoxin activity of (+)-cyanidanol-3 in experimental hepatitis in the rat. Hepatogastroenterology 1982 0.75
48 [Anti-endotoxin therapy in liver diseases]. G Ital Chemioter 1981 0.75
49 Prevalence, diagnosis and treatment of lower genital neoplasia in women with human immunodeficiency virus infection. Eur J Obstet Gynecol Reprod Biol 1992 0.75
50 [Immunopathology of HTLV III infection in drug addicts]. Boll Ist Sieroter Milan 1986 0.75
51 Flavonoids and hepatic cyclic monophosphates in liver injury. Boll Ist Sieroter Milan 1984 0.75
52 Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series. Eur Rev Med Pharmacol Sci 2010 0.75
53 Neuropsychological and neurophysiological abnormalities in HIV-infection. Their relevance and predictive value. Acta Neurol (Napoli) 1990 0.75
54 [Comparative statistical study of erythropoiesis in HBsAg- and HBsAg+ hepatitis]. Riv Emoter Immunoematol 1977 0.75